Prostate Cancer Grading & Staging

Key points
- The Gleason grading system is the most commonly employed grading system in the United States.
- The TNM staging system for CaP is presented in Table 22-3 (American Joint Committee on Cancer, 1997).
- It is truly a system that relies upon the low-power appearance of the glandular architecture under the microscope.
- In assigning a grade to a given tumor, pathologists assign a primary grade to the pattern of cancer that is most commonly observed and a secondary grade to the second most commonly observed pattern in the specimen.
Grading & Staging
The Gleason grading system is the most commonly employed grading system in the United States. It is truly a system that relies upon the low-power appearance of the glandular architecture under the microscope. In assigning a grade to a given tumor, pathologists assign a primary grade to the pattern of cancer that is most commonly observed and a secondary grade to the second most commonly observed pattern in the specimen. Grades range from 1 to 5. If the entire specimen has only one pattern present, then both the primary and secondary grade are reported as the same grade. The Gleason score or Gleason sum is obtained by adding the primary and secondary grades together. As Gleason grades range from 1 to 5, Gleason scores or sums thus range from 2 to 10. Well-differentiated tumors have a Gleason sum of 2-4; moderately differentiated tumors have a Gleason sum of 5-6; and poorly differentiated tumors have a Gleason sum of 8-10. Historically, tumors having a Gleason sum of 7 have sometimes been grouped with the moderately differentiated tumors and at other times with the poorly differentiated tumors. One point that needs to be clarified is that the primary Gleason grade is perhaps the most important with respect to placing patients in prognostic groups. This is most important in assessing patients with a Gleason sum of 7. Patients with a Gleason sum of 7 who have a primary Gleason grade of 4 (4 + 3) tend to have a worse prognosis than those who have a primary Gleason grade of 3 (3 + 4). Many clinical series have failed to distinguish between these two populations and, therefore, caution must be exercised in reviewing these series.
Gleason grades 1 and 2 are characterized by small, uniformly shaped glands, closely packed, with little intervening stroma. Gleason grade 3 is characterized by variable-sized glands that percolate between normal stroma. A variant of Gleason grade 3 is referred to as a cribriform pattern. Here a small mass of cells is perforated by several gland lumens with no intervening stroma.
This results in a cookie-cutter-like appearance of cell nests. The border of these cribriform glands is smooth. Gleason grade 4 has several histologic appearances. The characteristic observation common to all Gleason grade 4 patterns is incomplete gland formation. Sometimes glands appear fused, sharing a common cell border. At other times sheets of cell nests are seen or long cords of cells are observed. Cribriform glands can also occur in Gleason grade 4, but the cell masses are large and borders tend to appear ragged, with infiltrating fingerlike projections. Gleason grade 5 usually has single infiltrating cells, with no gland formation or lumen appearance. Comedocarcinoma is an unusual variant of Gleason grade 5 carcinoma that has the appearance of cribriform glands with central areas of necrosis.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsNew study reveals how to improve chemotherapy use in prostate cancer
Prostate cancer is the second leading cause of cancer for men in the United States. Only one class of chemotherapy called taxanes is effective against the disease. A study published online this week (January 17th) in…
18 February 2015
NewsHow does prostate cancer form?
Prostate cancer affects more than 23,000 men this year in the USA however the individual genes that initiate prostate cancer formation are poorly understood. Finding an enzyme that regulates this process could provide…
19 December 2014
NewsCommon prostate cancer treatment associated with decreased survival in older men
A common prostate cancer therapy should not be used in men whose cancer has not spread beyond the prostate, according to a new study led by researchers at Henry Ford Hospital. The findings are particularly important for…





